Abstract
The no-reflow phenomenon is a serious complication following primary percutaneous coronary intervention (PPCI) in patients presenting with ST-segment elevation myocardial infarction (STEMI). Despite successful reopening of the epicardial coronary artery, inadequate myocardial perfusion persists due to microvascular obstruction and tissue-level reperfusion failure. No-reflow is associated with larger infarct size, ventricular dysfunction, heart failure, arrhythmias, and increased mortality. Identifying predictors of no-reflow is critical for risk stratification and preventive interventions. This study reviews the pathophysiology, clinical significance, predictors, diagnostic approaches, and management strategies of no-reflow following primary PCI. Through extensive literature synthesis, a predictive framework is proposed to guide clinicians in identifying high-risk patients and improving procedural outcomes.